Johnson & Johnson CEO: Fix the Drug Pricing Process, But Not Too Much I Fortune
J&J gets nearly half of its $76 billion in revenue from medications like Tylenol and cancer-fighing drugs.
Susie Gharib in conversation with Johnson & Johnson CEO Alex Gorsky – for the full article, go to http://fortune.com/2018/12/04/johnson-johnson-ceo-alex-gorsky/?!
Subscribe to Fortune –
http://www.youtube.com/subscription_center?add_user=FortuneMagazineVideo